A framework for the role of acute inflammation in tumor progression Gabriela SzalayovaTed A. JamesMercedes Rincon Review 19 April 2015 Pages: 235 - 238
Predictive factors of nipple involvement in breast cancer: a systematic review and meta-analysis Hanwen ZhangYaming LiQifeng Yang Review 19 April 2015 Pages: 239 - 249
Adjuvant dose-dense chemotherapy in breast cancer: a systematic review and meta-analysis of randomized trials Fausto PetrelliMary CabidduSandro Barni Review 28 April 2015 Pages: 251 - 259
Incidental primary breast cancer detected on PET–CT A. P. BenvenisteE. M. MaromWei Yang Review 01 May 2015 Pages: 261 - 268
miR-218 targets survivin and regulates resistance to chemotherapeutics in breast cancer Yunhui HuKun XuErnesto Yagüe Preclinical Study 22 April 2015 Pages: 269 - 280
Targeting breast cancer stem cells in triple-negative breast cancer using a combination of LBH589 and salinomycin Masaya KaiNoriko KanayaShiuan Chen Preclinical Study 23 April 2015 Pages: 281 - 294
Genome-wide analysis of alternative transcripts in human breast cancer Ji WenKevin H. ToomerXiaodong Cai Preclinical study 26 April 2015 Pages: 295 - 307
Progesterone receptor A predominance is a discriminator of benefit from endocrine therapy in the ATAC trial Patricia A. MoteAnne GompelChristine L. Clarke Preclinical study 28 April 2015 Pages: 309 - 318
Exome sequencing of contralateral breast cancer identifies metastatic disease Daniel KlevebringJohan LindbergKamila Czene Preclinical study 29 April 2015 Pages: 319 - 324
Markers of progression in early-stage invasive breast cancer: a predictive immunohistochemical panel algorithm for distant recurrence risk stratification Mohammed A. AleskandaranyD. SoriaE. A. Rakha Preclinical study 08 May 2015 Pages: 325 - 333
AroER tri-screen™ is a novel functional assay to estimate both estrogenic and estrogen precursor activity of chemicals or biological specimens Noriko KanayaDuc M. NguyenShiuan Chen Preclinical study 12 May 2015 Pages: 335 - 345
The clinical utility of assessment of the axilla in women with suspicious screen detected breast lesions in the post Z0011 era Gelareh FarshidJames KolliasP. Grantley Gill Clinical trial 23 April 2015 Pages: 347 - 355
Moderate level of HER2 expression and its prognostic significance in breast cancer with intermediate grade Tanja IgnatovHolm EggemannAtanas Ignatov Clinical trial 30 April 2015 Pages: 357 - 364
Incidental radiation to uninvolved internal mammary lymph nodes in breast cancer Divya AroraJessica FrakesEleanor Harris Clinical Trial 01 May 2015 Pages: 365 - 372
CYP19A1 polymorphisms and clinical outcomes in postmenopausal women with hormone receptor-positive breast cancer in the BIG 1–98 trial Brian Leyland-JonesKathryn P. GrayMeredith M. Regan Clinical Trial 03 May 2015 Pages: 373 - 384
Weight lifting and appendicular skeletal muscle mass among breast cancer survivors: a randomized controlled trial Justin C. BrownKathryn H. Schmitz Clinical Trial 03 May 2015 Pages: 385 - 392
Impact of adjuvant taxane-based chemotherapy on development of breast cancer-related lymphedema: results from a large prospective cohort Meyha N. SwaroopChantal M. FergusonAlphonse G. Taghian Clinical trial Open access 05 May 2015 Pages: 393 - 403
Relative dose intensity and therapy efficacy in different breast cancer molecular subtypes: a retrospective study of early stage breast cancer patients treated with neoadjuvant chemotherapy Jia-qi YuanShou-man WangFei-yu Chen Clinical Trial 09 May 2015 Pages: 405 - 413
Premenopausal plasma carotenoids, fluorescent oxidation products, and subsequent breast cancer risk in the nurses’ health studies Julia S. SistiSara LindströmA. Heather Eliassen Epidemiology 28 April 2015 Pages: 415 - 425
Validation of self-reported post-treatment mammography surveillance among breast cancer survivors by electronic medical record extraction method Jasmin A. TiroJoanne M. SandersSally W. Vernon Epidemiology 29 April 2015 Pages: 427 - 434
Prospective evaluation of alcohol consumption and the risk of breast cancer in BRCA1 and BRCA2 mutation carriers Cezary CybulskiJan LubinskiJoanne Kotsopoulos Epidemiology 03 May 2015 Pages: 435 - 441
Invasive micropapillary mucinous carcinoma of the breast is associated with poor prognosis Fangfang LiuMu YangLi Fu Epidemiology 08 May 2015 Pages: 443 - 451
Body mass index associated with genome-wide methylation in breast tissue Brionna Y. HairZongli XuMelissa A. Troester Epidemiology 08 May 2015 Pages: 453 - 463
Comparison of breast cancer risk in women with and without systemic lupus erythematosus in a Medicare population Waseem KhaliqRehan QayyumDiane M. Becker Epidemiology 10 May 2015 Pages: 465 - 474
Interpretation of genomic variation and disease association: the great missense mutation challenge! Tú Nguyen-DumontIngrid WinshipMelissa C. Southey Letter to the Editor 22 April 2015 Pages: 475 - 476
RETRACTED ARTICLE: Enhancement of doxorubicin efficacy through suppression of serine synthesis in triple-negative breast cancer Feng WangYong Yang Retracted Article 24 January 2015 Pages: 477 - 477
Retraction Note to: Suppression of the xCT–CD44v antiporter system sensitizes triple-negative breast cancer cells to doxorubicin Feng WangYong Yang Retraction Note 01 May 2015 Pages: 479 - 479
